Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 246

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD

Open access
Lim, Grace En Hui, Tang, Ansel, Ng, Cheng Han, Chin, Yip Han, Lim, Wen Hui, Tan, Darren Jun Hao, Yong, Jie Ning, Xiao, Jieling, Lee, Chloe Wen-Min, Chan, Mark, Chew, Nicholas WS., Xuan Tan, Eunice Xiang, Siddiqui, Mohammad Shadab, Huang, Daniel, Noureddin, Mazen, Sanyal, Arun J., Muthiah, Mark D. · 2023 · Clinical Gastroenterology and Hepatology

Abstract

BACKGROUND AND AIMS The shift to redefine non-alcoholic fatty liver disease (NAFLD) as metabolic associated fatty liver disease (MAFLD) can profoundly affect patient care, healthcare professionals, and progress within the field. To date, there remains no consensus on the characterization of NAFLD versus MAFLD. Thus, this study sought to compare the differences between the natural history of NAFLD and MAFLD. METHODS Medline and Embase databases were searched to include articles on prevalence, risk factors, or outcomes of patients with MAFLD or NAFLD. Meta-analysis of proportions was conducted using the generalized linear mix model. Risk factors and outcomes were evaluated in conventional pairwise meta-analysis. RESULTS 22 articles involving 379,801 patients were included. Pooled prevalence of MAFLD was 39.22% (CI: 30.96% - 48.15%) with the highest prevalence in Europe, Asia, followed by North America. The current MAFLD definition only accounted for 81.59% (CI: 66.51% - 90.82%) of NAFLD diagnosis. Patients had increased odds of being diagnosed with MAFLD compared to NAFLD (OR: 1.37, CI: 1.16-1.63, p<0.001). Imaging modality resulted in a significantly higher odds of being diagnosed with MAFLD compared to NAFLD, but not biopsy. MAFLD was significantly associated with males, higher BMI, hypertension, diabetes, lipids, transaminitis, and greater fibrosis scores compared to NAFLD. CONCLUSION There were stark differences in the prevalence and risk factors between MAFLD and NAFLD. However, in the use of the MAFLD definition, a greater emphasis on the management of concomitant metabolic diseases and a collaborative effort is required to explore the complex pathophysiologic mechanisms underlying the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2021.11.038

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 246

Metadata

Authors
Lim, G. E. H., Tang, A., Ng, C. H., Chin, Y. H., Lim, W. H., Tan, D. J. H., Yong, J. N., Xiao, J., Lee, C. W.-M., Chan, M., Chew, N. W., Xuan Tan, E. X., Siddiqui, M. S., Huang, D., Noureddin, M., Sanyal, A. J., & Muthiah, M. D.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2023-03
Volume
21
Issue
3
Pages
619-629.e7
ISSN
1542-3565 (ISSN-L)
OpenAlex
W4200156908
Cited by
246
References
13
FWCI
8.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD. https://app.cochat.ai/papers/10.1016/j.cgh.2021.11.038
The paper
Lim, G. E. H., Tang, A., Ng, C. H., Chin, Y. H., Lim, W. H., Tan, D. J. H., Yong, J. N., Xiao, J., Lee, C. W.-M., Chan, M., Chew, N. W., Xuan Tan, E. X., Siddiqui, M. S., Huang, D., Noureddin, M., Sanyal, A. J., & Muthiah, M. D. (2023). An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2021.11.038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.